Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB treatment news

Show

From To
African Health Ministers Commit to Ramped Up TB/HIV Treatment

Health ministers from Swaziland and South Africa have agreed to radically change the diagnosis and treatment of the co-epidemic of TB/HIV in their countries.

Published
3 hours ago
From
Voice of America
An Activist’s Guide to Bedaquiline (Sirturo)

Bedaquiline (also known by its trade name, Sirturo, or as TMC207) is the first new drug from a new drug class to treat TB to be approved by the United States Food and Drug Administration (FDA) in over 40 years. This guide highlights important safety and efficacy data reported thus far and offers advocacy recommendations for activists to take forward. .

Published
12 March 2013
From
Treatment Action Group
In India, Fighting TB with Fingerprints

Health specialists in India are using fingerprint technology to make sure tuberculosis sufferers receive proper treatment for the deadly lung infection.

Published
28 February 2013
From
Voice of America
CDC report on U.S. TB drug shortage reflects local and global challenges

According to an article in this week’s Morbidity and Mortality Weekly Report, the 26 health departments handling about 75 percent of the United States tuberculosis caseload have confronted multidrug-resistant tuberculosis, with 21 of those departments — more than 80 percent – facing obstacles to getting the medicine necessary to treat it.

Published
21 January 2013
From
Science Speaks
US Food and Drug Administration approves Sirturo (bedaquiline) to treat MDR TB in adults

The US drug licensing authority has approved the first drug to be developed for multidrug-resistant tuberculosis (MDR TB). Bedaquiline is the first new TB and antimycobacterial drug of any kind to be approved since rifabutin in 1992, and the first new class of drugs for 45 years, since rifampicin in 1967.

Published
02 January 2013
From
FDA
Treatment Action Group welcomes FDA review of first new tuberculosis drug in half a century

“The decision you make today is going to affect millions of people around the world,” TAG executive director Mark Harrington said today to the FDA Center for Drug Evaluation and Research at the landmark Anti-Infective Drugs Advisory Committee Meeting.

Published
29 November 2012
From
Treatment Action Group
New type of TB drug deemed safe by FDA

A tuberculosis drug under review by the FDA seems to work well in combination with other treatments while appearing to be "safe and well-tolerated," the agency said. Bedaquiline (Sirturo) could provide help in treating multi-drug resistant Mycobacterium tuberculosis, the FDA said in briefing documents released ahead of an advisory committee.

Published
28 November 2012
From
MedPage Today
Paper Test Could Make Drug Treatment Safer

Researchers looking to make tuberculosis (TB) and HIV treatment safer have developed a paper-based test for drug-induced liver damage.

Published
19 November 2012
From
Asian Scientist Magazine
Scientists to study the role genes play in treating TB

The University of Liverpool has been awarded funding to determine whether differences in our genes determine how patients respond to drugs used to treat Tuberculosis in Sub-Saharan Africa.

Published
26 October 2012
From
Eurekalert Inf Dis
Structure discovered for promising tuberculosis drug target

Researchers at Johns Hopkins have figured out the three-dimensional shape of the protein responsible for creating unique bonds within the cell wall of the bacteria that cause tuberculosis. The bonds make the bacteria resistant to currently available drug therapies, contributing to the alarming rise of these super-bacteria throughout the world.

Published
26 October 2012
From
Eurekalert Inf Dis
← First12345Next →

Filter by country